UnitedHealth Group Faces Market Challenges Amid Rising Healthcare Costs
UnitedHealth Group stock struggles as rising healthcare costs pressure financial performance, highlighting key market and regulatory challenges in 2024.
Navigating Employer Health Insurance Selection for 2026 Coverage
Understanding the complexities of employer health insurance plan selection for 2026 can improve employee decision-making during open enrollment. Clear employer communication is key.
ACA Subsidy Expiration Drives Health Insurance Premium Increases and Market Risks
Expiration of ACA subsidies leads to significant health insurance premium hikes, raising affordability concerns and potential adverse selection in the U.S. insurance market.
Colorado ACA Marketplace Sees 5% Enrollment Dip Amid Premium Increases
Connect for Health Colorado reports a 5% enrollment decrease for 2026 as federal premium tax credits expire and insurers plan a 28% average rate increase, impacting health insurance affordability.
Insurance Challenges Delay FDA-Approved Scoliosis Surgery Coverage
Discover the insurance challenges surrounding FDA-approved vertebral body tethering for scoliosis. Understand insurer denial reasons, clinical outcomes, and impact on patient care.
GAO Report Reveals Extensive Fraud Risks in ACA Marketplace Subsidies
GAO uncovers major fraud vulnerabilities in ACA marketplace subsidies, highlighting risks in identity verification and the need for systemic reforms to protect taxpayer funds and stabilize premiums.
CMS Finalizes 2026 Payment Updates and Policy Changes for OPPS and ASCs
CMS announces 2026 updates for OPPS and ASC payment systems, including expanded site neutral payments, skin substitute product unbundling, IPO list phase-out, and new hospital price transparency requirements.
Medicare for All Gains Broad U.S. Support Amid Rising Premiums and ACA Limitations
A new poll shows growing public support for Medicare for All in the U.S., reflecting dissatisfaction with rising private insurance premiums and limitations of the Affordable Care Act.
CMS Medicare Drug Price Negotiations Yield $12B Savings on 15 High-Cost Medications
CMS announces $12 billion savings from Medicare drug price negotiations on 15 high-cost medications, effective 2027, enhancing Medicare Part D sustainability.
CMS Proposes Major 2027 Medicare Advantage and Part D Updates Following Inflation Reduction Act
CMS's 2027 proposed rule outlines key Medicare Advantage and Part D program updates, codifying Inflation Reduction Act changes, adjusting Star Ratings, and modernizing marketing and risk adjustment frameworks.